BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10208176)

  • 41. Fragile X syndrome: a clinico-genetic study of mentally retarded patients in Kuwait.
    Bastaki LA; Hegazy F; Al-Heneidi MM; Turki N; Azab AS; Naguib KK
    East Mediterr Health J; 2004; 10(1-2):116-24. PubMed ID: 16201716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo footprinting analysis of the FMR1 gene: proposals concerning gene regulation in high-functioning males.
    Schwemmle S
    Am J Med Genet; 1999 May; 84(3):266-7. PubMed ID: 10331604
    [No Abstract]   [Full Text] [Related]  

  • 43. The CGG repeat and the FMR1 gene.
    Stoyanova V; Oostra BA
    Methods Mol Biol; 2004; 277():173-84. PubMed ID: 15201456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnosis of fragile X syndrome].
    Glover G; Bernabé MJ; Carbonell P
    Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fragile balance: FMR1 expression levels.
    Oostra BA; Willemsen R
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R249-57. PubMed ID: 12952862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-invasive screening of fragile X syndrome A using urine and hair roots.
    Suwa K; Momoi MY
    Brain Dev; 2004 Sep; 26(6):380-3. PubMed ID: 15275700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal diagnosis of fragile X syndrome: (CGG)n expansion and methylation of chorionic villus samples.
    Castellví-Bel S; Milà M; Soler A; Carrió A; Sánchez A; Villa M; Jiménez MD; Estivill X
    Prenat Diagn; 1995 Sep; 15(9):801-7. PubMed ID: 8559749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dilemmas in counselling females with the fragile X syndrome.
    de Vries BB; van den Boer-van den Berg HM; Niermeijer MF; Tibben A
    J Med Genet; 1999 Feb; 36(2):167-70. PubMed ID: 10051021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal fragile X detection using cytoplasmic and nuclear-specific monoclonal antibodies.
    Jenkins EC; Wen GY; Kim KS; Zhong N; Sapienza VJ; Hong H; Chen J; Li SY; Houck GE; Ding X; Nolin SL; Dobkin CS; Brown WT
    Am J Med Genet; 1999 Apr; 83(4):342-6. PubMed ID: 10208177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal diagnosis of fragile X syndrome by direct detection of the dynamic mutation due to an unstable DNA sequence.
    Yamauchi M; Nagata S; Seki N; Toyama Y; Harada N; Niikawa N; Masuno I; Kajii T; Hori T
    Clin Genet; 1993 Oct; 44(4):169-72. PubMed ID: 8261644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incomplete EcoRI digestion may lead to false diagnosis of fragile X syndrome.
    Storm K; Handig I; Reyniers E; Oostra BA; Kooy RF; Willems PJ
    Hum Genet; 1998 Jan; 102(1):54-6. PubMed ID: 9490298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid antibody test for prenatal diagnosis of fragile X syndrome on amniotic fluid cells: a new appraisal.
    Willemsen R; Los F; Mohkamsing S; van den Ouweland A; Deelen W; Galjaard H; Oostra B
    J Med Genet; 1997 Mar; 34(3):250-1. PubMed ID: 9132500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region.
    Trottier Y; Imbert G; Poustka A; Fryns JP; Mandel JL
    Am J Med Genet; 1994 Jul; 51(4):454-7. PubMed ID: 7943018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenatal diagnosis of sickle cell anemia using PCR and restriction enzyme Dde I.
    Gürgey A; Beksaç S; Mesci L; Cakar N; Karakaş U; Kutlar A; Altay C
    Turk J Pediatr; 1993; 35(3):159-62. PubMed ID: 7909397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prenatal genetic counseling: what is fragile X?
    Bodurtha J; Tams L; Jackson-Cook C
    Va Med Q; 1992; 119(2):97-8. PubMed ID: 1562624
    [No Abstract]   [Full Text] [Related]  

  • 58. [The prenatal diagnosis of hemophilia A--the use of PCR and family RFLP analysis].
    Bian M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):102-7. PubMed ID: 7902217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Denaturing gradient gel electrophoresis of the alpha 1-antitrypsin gene: application to prenatal diagnosis.
    Dubel JR; Finwick R; Hejtmancik JF
    Am J Med Genet; 1991 Oct; 41(1):39-43. PubMed ID: 1951462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal diagnosis of fragile X syndrome.
    Willemsen R; Oosterwijk JC; Los FJ; Galjaard H; Oostra BA
    Lancet; 1996 Oct; 348(9032):967-8. PubMed ID: 8843844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.